Hereditary ovarian carcinoma. Biomarker studies
β Scribed by Henry T. Lynch; Guy S. Schuelke; Ibert C. Wells; Shih-Chuan Cheng; William J. Kimberling; Karen A. Biscone; Jane F. Lynch; B. Shannon Danes
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 571 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Three ovarian-cancer-prone kindreds were studied, two of which contained identical twin sisters concordant for ovarian carcinoma. In one kindred, both identical twin sisters had daughters with ovarian carcinoma. In another kindred, one of the identical twin sisters had an ovarian-cancer-affected daughter. Ovarian carcinoma showed vertical transmission in all three families in a pattern consonant with an autosomal dominant mode of inheritance. Medical -genetic survey of each family included detailed questionnaires with retrieval of primary medical and pathology documents on cancer of all anatomic sites. Putative biomarker determinations included: (I) in vitro hyperdiploidy in dermal monolayer cultures; and (2) lower serum levels of alpha-L-fucosidase (5 275 IU/ml) in all cancer-affected patients and statistically significant lower levels in 50% risk individuals when compared to spouse and published controls (P = 0.04 and P = 0.0002, respectively). These findings are discussed in context with the eventual development of a risk factor profile which, given acceptable sensitivity and specificity, would enable identification of individuals who would be prime candidates for intensive surveillance/management programs.
π SIMILAR VOLUMES
## Abstract Inflammation and gonadotropins are hypothesized to influence ovarian carcinogenesis. In a prospective study, we evaluated ovarian cancer risk associated with selfβreported use of medications that influence inflammation or gonadotropin levels. The Breast Cancer Detection Demonstration Pr
Background. The search for methods of early detection of ovarian carcinoma in recent years has emphasized the lack of information regarding the histologic features of early carcinoma or its precursor lesions; few examples of early de novo ovarian carcinoma have been reported. Methods. The clinicopa
## Abstract ## BACKGROUND The HERβ2 (Human Epidermal Growth factor receptorβ2, also known as cβ__erb__β2/__neu__) protooncogene encodes a transmembrane receptor protein, __M__~r~ 185,000. Studies have shown that the HERβ2 oncogene is overexpressed in approximately 25β30% of ovarian carcinoma (OC)